Structures by: Theiner S.
Total: 14
(OC-6-22)-((1R,2R)-diaminocyclohexane)bis(oxalato)platinum(IV)
C10H14N2O8Pt,2(C3H7NO)
Journal of medicinal chemistry (2014) 57, 15 6751-6764
a=8.9059(5)Å b=11.2218(6)Å c=22.0760(11)Å
α=90.00° β=90.00° γ=90.00°
(OC-6-22)-ethane-1,2-diamine(3-methylmalonato)platinum(IV)
C10H16,N2O8Pt,C3H7NO,C3H6O,H2O
Journal of medicinal chemistry (2014) 57, 15 6751-6764
a=13.8623(4)Å b=8.6180(2)Å c=18.7397(5)Å
α=90.00° β=97.8410(10)° γ=90.00°
Bis[((1-benzyl-2-methyl-3-(oxo-κO)-pyridine-4(1H)- thionato-κS)(η6-p-cymene) ruthenium(II)) iodide]
2(I),C46H52N2O2Ru2S2,CH4O
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=19.6766(16)Å b=10.0026(10)Å c=24.018(2)Å
α=90° β=92.308(4)° γ=90°
[(Thioatocarbonyldiamine-κS)(1-benzyl-2-methyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)](η6-p-cymene)ruthenium(II)] chloride
C24H30N3ORuS2,Cl
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=10.107(2)Å b=11.107(2)Å c=12.096(2)Å
α=90° β=108.775(8)° γ=90°
[(1-Methyl-1H-imidazole-κN3)(1,2-dimethyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)(η6-p-cymene)ruthenium(II)] hexafluorophosphate
C21H28N3ORuS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=9.5074(2)Å b=10.0971(3)Å c=13.5952(4)Å
α=74.3060(9)° β=77.5332(9)° γ=87.8246(11)°
[(1,3,5-Triaza-7-phosphaadamantane-κP)(1,2-Dimethyl-3-oxo-κO-pyridine- 4(1H)-thionato-κS)(η6-p-cymene)ruhtenium(II)] hexafluorophosphate
C23H34N4OPRuS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=8.8476(5)Å b=11.4425(6)Å c=13.8462(7)Å
α=82.475(2)° β=79.907(2)° γ=88.353(2)°
[(1-Methyl-1H-imidazole-κN3)(1-benzyl-2-methyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)rhodium(III)] hexafluorophosphate
C27H33N3ORhS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=9.8382(3)Å b=12.2093(4)Å c=14.1367(5)Å
α=67.1738(11)° β=80.8485(12)° γ=68.3017(11)°
[(1-Methyl-1H-imidazole-κN3)(1-benzyl-2-methyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)(η6-p-cymene)ruhtenium(II)] hexafluorophosphate
C27H32N3ORuS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=10.3415(3)Å b=11.8930(3)Å c=13.3257(4)Å
α=67.1050(10)° β=88.0280(10)° γ=76.6230(10)°
[(1-Methyl-1H-imidazole-κN3)(1-benzyl-2-methyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)iridium(III)] hexafluorophosphate
C27H33IrN3OS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=9.8020(5)Å b=12.3228(6)Å c=13.9774(7)Å
α=68.0585(16)° β=81.3239(17)° γ=69.4402(17)°
[(1,3,5-Triaza-7-phosphaadamantane-κP)(1-benzyl-2-methyl-3-oxo-κO-pyridine- 4(1H)-thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)rhodium(III)] hexafluorophosphate
C29H39N4OPRhS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=9.4865(4)Å b=13.5259(8)Å c=13.5730(8)Å
α=68.784(2)° β=84.539(3)° γ=78.200(3)°
[(1-Methyl-1H-imidazole-κN3)(1,2-dimethyl-3-oxo-κO-pyridine-4(1H)-thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)rhodium(III)] hexafluorophosphate
C21H29N3ORhS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=8.7282(5)Å b=16.3364(10)Å c=17.8947(11)Å
α=93.913(2)° β=97.756(2)° γ=90.927(3)°
[(1,3,5-Triaza-7-phosphaadamantane-κP)(1,2-Dimethyl-3-oxo-κO-pyridine-4(1H)-thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)rhodium(III)]hexafluorophosphate
0.5(C23H35N4OPRhS),0.5(C23H34N4OPRhS),F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=21.070(3)Å b=9.9943(14)Å c=31.846(4)Å
α=90° β=99.318(5)° γ=90°
[(1,3,5-Triaza-7-phosphaadamantane-κP)(1-benzyl-2-methyl-3-oxo-κO-pyridine- 4(1H)-thionato-κS)(η6-p-cymene)ruthenium(II)] hexafluorophosphate
C29H38N4OPRuS,2(CH2Cl2),F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=12.3099(3)Å b=12.4123(4)Å c=14.4636(4)Å
α=65.2024(11)° β=70.4638(11)° γ=77.0040(11)°
[(1-Methyl-1H-imidazole-κN3)(1,2-dimethyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)iridium(III)] hexafluorophosphate
C21H29IrN3OS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=8.77040(10)Å b=16.4092(2)Å c=18.0771(3)Å
α=93.7892(5)° β=97.5756(5)° γ=90.7492(5)°